Clinical trial
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
NCT00432094 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00432094 |
|---|---|
| Title | Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors |
| Official title | Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Childhood Germ Cell Tumor, Ovarian Cancer, Teratoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | carboplatin, etoposide, ifosfamide, paclitaxel, thiotepa, autologous hematopoietic stem cell transplantation, Mesna, filgrastim |
| Enrollment | 23 |
| Start date | Dec 19, 2006 |
| Primary completion | Mar 1, 2021 |
| Completion | Mar 1, 2021 |
| First posted | Feb 7, 2007 |
| Last update posted | May 17, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: